Nevertheless, a group of more than 10 D2R antagonists exhibited a strong association between their use and the emergence of dyskinesia with higher ROR and z scores (Figure 1A and Supplemental Table 1; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.145632DS1). The gene discussed is DRD2; the disease is Dyskinesia.